Recombinant human TSH (rhTSH) is used to evaluate thyroid carcinoma patients and off-label for 131I thyroid ablation and nontoxic goiter therapy...Conclusions: Marked increases in RAIU occurred when 123I was given 24 h after rhTSH administration to euthyroid volunteers. Smaller increases were observed at 48 h and none at 72 h